[3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone
C27H26FN5O3 — CID 118662711
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone
[3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone (PubChem CID 118662711) has the molecular formula C27H26FN5O3 and a molecular weight of 487.54 g/mol. Its IUPAC name is [3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone.
Molecular Properties
| Compound Name | [3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone |
|---|---|
| PubChem CID | 118662711 |
| Molecular Formula | C27H26FN5O3 |
| Molecular Weight | 487.54 g/mol |
| Exact Mass | 487.20 |
| IUPAC Name | [3-cyclopropyl-1-[5-[2-fluoro-5-(1-hydroxyethyl)phenyl]pyrimidin-2-yl]indazol-6-yl]-morpholin-4-ylmethanone |
| SMILES | CC(O)c1ccc(F)c(-c2cnc(-n3nc(C4CC4)c4ccc(C(=O)N5CCOCC5)cc43)nc2)c1 |
| InChI | InChI=1S/C27H26FN5O3/c1-16(34)18-5-7-23(28)22(12-18)20-14-29-27(30-15-20)33-24-13-19(26(35)32-8-10-36-11-9-32)4-6-21(24)25(31-33)17-2-3-17/h4-7,12-17,34H,2-3,8-11H2,1H3 |
| InChIKey | GOXWCWKIRIKVGI-UHFFFAOYSA-N |
| XLogP | 4.02 |
| TPSA | 93.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.54 |
| LogP ≤ 5 | 4.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118662711 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.